Get startedLog in
    Picture of Dishman Carbogen Amcis logo

    DCAL — Dishman Carbogen Amcis Income Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Dishman Carbogen Amcis, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    C2020
    March 31st
    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue20,43619,12021,40724,12926,158
    Cost of Revenue
    Gross Profit15,08313,87416,19917,97219,006
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses18,11219,51721,25523,55626,304
    Operating Profit2,324-397152573-146
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes1,972-650-42.5-546-1,223
    Provision for Income Taxes
    Net Income After Taxes1,585-1,651180-298-1,535
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income1,585-1,651180-298-1,535
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income1,585-1,651180-298-1,535
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS15.3-3.978.243.6-6.01
    Dividends per Share